Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER
Both guselkumab regimens superior to placebo
30.5 percent of school principals report that their district mandated school screening; rates of screening higher in larger schools
High levels of anxiety, depression, stigma, and impaired QoL reported by many patients; all linked to perceptions of illness
Each additional healthy lifestyle factor associated with 17 percent lower risk for overactive bladder
Model was significantly better than parametric logistic regression and LASSO models for predicting inpatient mortality
Low Prognostic Nutritional Index and high systemic oxidative stress score independently associated with poorer prognosis
No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users
Rates higher during and since the pandemic, particularly among primary care physicians
Tidmarsh's areas of expertise include pediatrics, pediatric oncology, and neonatology
GLP-1 receptor agonist use linked to lower risk for overall dementia, Alzheimer disease, nonvascular dementia compared with metformin
Top concerns include life expectancy, course of treatment, and pain
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
23.8 and 50.4 percent of those with one and two or more moderate risk factors were recommended aspirin prophylaxis
More than one-third of all admissions for adults with autism in 2019 were for mental health